CYP19A1 and breast carcinoma: Specific roles for CYP3A4 and CYP19A1 in breast cancer therapy response have been reviewed [73, 74], but only preliminary considerations have been made for modeling the concurrent and opposing activities of these enzymes on therapies within the same treatment regimen.